AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Twist Bioscience Corp Director's Dealing 2021

Aug 26, 2021

31873_dirs_2021-08-26_1d50258b-47ca-4245-bd0a-247385c0eacb.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Twist Bioscience Corp (TWST)
CIK: 0001581280
Period of Report: 2021-08-24

Reporting Person: Finn Patrick John (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-08-24	Common Stock	S	91	$108.26	Disposed	39823	Direct

Footnotes

F1: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on September 3, 2020.